KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $135.0 million.

  • Thermo Fisher Scientific's Restructuring Costs rose 20000.0% to $135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $543.0 million, marking a year-over-year increase of 13506.49%. This contributed to the annual value of $379.0 million for FY2024, which is 1742.92% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Restructuring Costs stood at $135.0 million for Q3 2025, which was up 20000.0% from $82.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Restructuring Costs ranged from a high of $228.0 million in Q4 2024 and a low of $2.0 million during Q2 2022
  • Its 5-year average for Restructuring Costs is $77.1 million, with a median of $77.0 million in 2024.
  • In the last 5 years, Thermo Fisher Scientific's Restructuring Costs crashed by 8571.43% in 2022 and then soared by 550000.0% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Restructuring Costs (Quarter) stood at $46.0 million in 2021, then rose by 19.57% to $55.0 million in 2022, then surged by 45.45% to $80.0 million in 2023, then skyrocketed by 185.0% to $228.0 million in 2024, then tumbled by 40.79% to $135.0 million in 2025.
  • Its Restructuring Costs stands at $135.0 million for Q3 2025, versus $82.0 million for Q2 2025 and $98.0 million for Q1 2025.